| Author | Year | Nation | Number of patients | Number of tumors | Tumor | Age | Design | Field | Index | value (s/m2) | |
| Mori et al. [8] | 2008 | Japan | 104 | 140 | Lung (various) | Adult | Prospective | 1.5 T | | 1000 | −0.504 | Ho et al. [9] | 2009 | Taiwan | 33 | 33 | Cervix (various) | Adult | Prospective | 3.0 T | / | 0 and 1000 | −0.526 | Palumbo et al. [10] | 2009 | USA | 15 | 18 | Brain (metastases) | Adult | N | 1.5 T | ADC-CR | N | −0.524 | Aoyagi et al. [11] | 2010 | Japan | 123 | 123 | Esophageal (SCC) | Adult | N | 1.5 T | ADC | 0 and 1000 | −0.398 | Nakajo et al. [12] | 2010 | Japan | 44 | 44 | Breast (ductal carcinoma) | Adult | Retrospective | 1.5 T | | 0 and 1000 | −0.486 | Punwani et al. [13] | 2010 | UK | 16 | 53 | Lymphoma (MCL) | Children | N | 1.5 T | | 500 | −0.38 | Tanimoto et al. [14] | 2010 | Japan | 16 | 16 | Pancreas (various) | Adult | N | 3.0 T | ADC | 400, 800, and 1200 | −0.48 | Choi et al. [15] | 2011 | Korea | 47 | 47 | Head and neck (SCC) | Adult | Retrospective | 1.5 T | | 1000 | −0.222 | Fruehwald-Pallamar et al. [16] | 2011 | Austria | 31 | 31 | Head and neck (SCC) | Adult | Prospective | 3.0 T | | 0 and 800 | −0.238 | Gu et al. [17] | 2011 | China | 33 | 33 | Rectum (adenocarcinoma) | Adult | N | 3.0 T | | 0 and 1000 | −0.45 | Ohba et al. [18] | 2011 | Japan | 58 | 76 | Lung (various) | N | Prospective | 1.5 T | | 1000 | −0.31 | Usuda et al. [19] | 2011 | Japan | 63 | 63 | Lung (various) | Adult | N | 1.5 T | | 0 and 800 | −0.286 | Wu et al. [20] | 2011 | Finland | 15 | 15 | Lymphoma (DLBCL) | Adult | Prospective | 3.0 T | | 0 and 800 | 0.215 | Cafagna et al. [21] | 2012 | Italy | 38 | 88 | Various | N | Retrospective | 1.5 T | ADC | 500 and 1000 | 0.238 | Choi et al. [22] | 2012 | Korea | 118 | 118 | Breast (IDC) | Adult | N | 1.5 and 3.0 T | | 0, 750, and 1000 | −0.025 | Matsushima et al. [23] | 2012 | Japan | 36 | 36 | Glioma and lymphoma | Children and adult | Retrospective | 1.5 T | | 1000 | −0.68 | Nakajo et al. [24] | 2012 | Japan | 26 | 26 | Head and neck (SCC) | Adult | Retrospective | 1.5 T | | 0 and 800 | −0.566 | Nakamatsu et al. [25] | 2012 | Japan | 24 | 41 | Metastatic neck lymph nodes of head and neck (SCC) | Adult | Retrospective | 1.5 T | | 0 and 1000 | −0.489 | Nakamura et al. [26] | 2012 | Japan | 66 | 66 | Cervix (various) | Adult | N | 1.5 T | | 0, 50, and 1000 | −0.529 | Regier et al. [27] | 2012 | Germany | 41 | 41 | Lung (NSCLC) | N | Prospective | 1.5 T | | 0 and 500 | −0.46 | Ahn et al. [28] | 2013 | Korea | 21 | 21 | Liver (HCC) | Adult | Retrospective | 3.0 T | | 50, 400, and 800 | 0.369 | Byun et al. [29] | 2013 | Korea | 75 | 75 | Breast (IDC) | Adult | Retrospective | 3.0 T | | 0 and 800 | −0.267 | Gong et al. [30] | 2013 | China | 7 | 21 | Metastatic GIST | Adult | Retrospective | 3.0 T | | 0, 150, and 1000 | −0.843 | Nakamura et al. [31] | 2013 | Japan | 131 | 131 | Endometria | Adult | Prospective | 1.5 T | | 0, 50, and 1000 | −0.677 | Rakheja et al. [32] | 2013 | USA | 24 | 69 | Various | Adult | N | 3.0 T | | 0, 350, and 750 | −0.29 | Schmidt et al. [33] | 2013 | Germany | 14 | 14 | Lung (various) | Adult | N | 3.0 T | | 0 and 800 | −0.8 | Tsuchida et al. [34] | 2013 | Japan | 28 | 28 | Lung (various) | Adult | N | 1.5 T | ADC | 0 and 800 | 0.043 | Varoquaux et al. [35] | 2013 | Switzerland | 33 | 34 | Head and neck (SCC) | Children and adult | Retrospective | 1.5 and 3.0 T | ADC | 0 and 1000 | −0.103 | Baba et al. [36] | 2014 | Japan | 79 | 83 | Breast (various) | Adult | Retrospective | 1.5 T | | 1000 | −0.36 | de Jong et al. [37] | 2014 | Netherlands | 21 | 21 | Lymphoma (DLBCL) | Adult | Prospective | 1.5 T | | 0 and 1000 | −0.103 | Er et al. [38] | 2014 | Turkey | 41 | 41 | Rectum (adenocarcinoma) | Adult | Retrospective | 3.0 T | | 50, 400, and 1000 | −0.347 | Giganti et al. [39] | 2014 | Italy | 17 | 17 | Gastric (adenocarcinoma) | Adult | Prospective | 1.5 T | | 0 and 600 | −0.01 | Grueneisen et al. [40] | 2014 | Germany | 15 | 54 | Cervix (various) | Adult | Prospective | 3.0 T | | 0, 500, and 1000 | −0.342 | Iizuka et al. [41] | 2014 | Japan | 15 | 15 | Lung (NSCLC) | Adult | N | 1.5 T | | 0, 500, and 1000 | 0.046 | Sakane et al. [42] | 2015 | Japan | 20 | 20 | Pancreas (adenocarcinoma) | Adult | Retrospective | 3.0 T | | 0 and 800 | −0.66 | Schwenzer et al. [43] | 2014 | Germany | 20 | 52 | Peritoneal carcinomatosis | Adult | Prospective | 3.0 T | | 50 and 800 | −0.58 | Sun et al. [44] | 2014 | China | 35 | 35 | Cervix (various) | Adult | Prospective | 3.0 T | | 0, 200, 500, and 1000 | −0.505 | Yu et al. [45] | 2014 | China | 8 | 34 | Peritoneal metastases | Adult | Prospective | 3.0 T | | 0, 400, and 800 | −0.548 | Zhang et al. [46] | 2014 | China | 113 | 113 | Lung (various) | Adult | N | 3.0 T | | 1000 | −0.37 | Zukotynski et al. [47] | 2014 | USA | 36 | 36 | Brain (BSG) | Children | Retrospective | 1.5 T | | 5 and 1000 | −0.54 | Brandmaier et al. [48] | 2015 | Germany | 14 | 14 | Cervix (various) | Adult | Prospective | 3.0 T | | 0 and 800 | −0.532 | Covello et al. [49] | 2015 | Italy | 44 | 44 | Head and neck (various) | Adult | N | 3.0 T | | 0, 500, and 800 | −0.36 | Han et al. [50] | 2015 | Korea | 34 | 34 | Head and neck (SCC) | Adult | Retrospective | 1.5 T | | 0 and 1000 | −0.333 | Heacock et al. [51] | 2015 | USA | 13 | 51 | Lymphoma (various) | Adult | Prospective | 3.0 T | | 0, 350, and 750 | 0.06 | Karan et al. [52] | 2016 | Turkey | 70 | 70 | Breast (IDC) | Adult | Retrospective | 1.5 T | | 0, 200, 600, and 800 | −0.112 | Littooij et al. [53] | 2015 | Netherlands | 11 | 19 | Lymphoma (various) | Children and adult | Prospective | 1.5 T | | 0 and 1000 | −0.24 | Liu et al. [54] | 2015 | China | 11 | 11 | Lung (various) | Adult | N | 1.5 T | | 1000 | −0.55 | Metz et al. [55] | 2015 | Germany | 12 | 12 | Lung (metastatic NSCLC) | Adult | Prospective | 1.5 T | | 50, 300, and 600 | 0.3 | Schaarschmidt et al. [56] | 2015 | Germany | 25 | 100 | Lymph node metastases of NSCLC | Adult | Retrospective | 3.0 T | | 0, 500, and 1000 | −0.36 |
|
|